https://orcid.org/0000-0002-6256-4982
ABSTRACT
In Canada and the US, the infant diet is supplemented with vitamin D via supplement drops or formula. Pregnant and nursing mothers often take vitamin D supplements. Since little is known about the impact of this supplementation on infant gut microbiota, we undertook a study to determine the association between maternal and infant vitamin D supplementation, infant gut microbiota composition and Clostridioides difficile colonization in 1,157 mother-infant pairs of the CHILD (Canadian Healthy Infant Longitudinal Development) Cohort Study over 2009–2012. Logistic and MaAsLin regression were employed to assess associations between vitamin D supplementation, and C. difficile colonization, or other gut microbiota, respectively. Sixty-five percent of infants received a vitamin D supplement. Among all infants, infant vitamin D supplementation was associated with a lower abundance of genus Megamonas (q = 0.01) in gut microbiota. Among those exclusively breastfed, maternal prenatal supplementation was associated with lower abundance of Bilophila (q = 0.01) and of Lachnospiraceae (q = 0.02) but higher abundance of Haemophilus (q = 0.02). There were no differences in microbiota composition with vitamin D supplementation among partially and not breastfed infants. Neither infant nor maternal vitamin D supplementation were associated with C. difficile colonization, after adjusting for breastfeeding status and other factors. However, maternal consumption of vitamin-D fortified milk reduced the likelihood of C. difficile colonization in infants (adjustedOR: 0.40, 95% CI: 0.19–0.82). The impact of this compositional difference on later childhood health, especially defense against viral respiratory infection, may go beyond the expected effects of vitamin D supplements and remains to be ascertained.
Introduction
Most infants in North America are supplemented with vitamin D subsequent to recommendations that all breastfed infants receive 400 IU/day, an amount that is also present in commercial infant formulas.Citation1,Citation2 However, infant vitamin D supplementation during breastfeeding is not common practice in Australia and several European countries, including Italy and Spain,Citation3,Citation4 and compliance rates in Canada and the US are moderate.Citation5,Citation6 Vitamin D has shown protective activity against the development of preschool wheeze when provided as a maternal prenatal supplement.Citation7 Supplementation of preterm infants with vitamin D has reduced recurrent wheeze in a randomized-controlled trial.Citation8 Independent of gestational age and breastfeeding status, infant supplementation before 6-months has shown future benefit in raising serum vitamin D levels and reducing hospital length-of-stay of infants hospitalized for bronchiolitis, a respiratory infection often caused by respiratory syncytial virus (RSV).Citation9 Of note, low vitamin D levels has been associated with susceptibility to other viral respiratory infections, including SARS-CoV-2 (COVID-19 disease).Citation10 Furthermore, the high rates of food allergy and recurrent wheeze in Australian children have been attributed to vitamin D insufficiency during infancy.Citation11
While the immunological roles (both innate and adaptive) of vitamin D have been extensively studied, vitamin D has many physiological roles important for the maintenance of gut microbiota and exclusion of opportunistic microbes. Vitamin D receptors (VDRs) are found on immune cells including T cells, B cells and dendritic cells, but are also highly expressed in intestinal enterocytes where they act as transcription factors for the secretion of antimicrobial peptides and tight junction proteins that maintain intestinal epithelial barrier function.Citation12,Citation13 Asystematic review of in vivo research has summarized the impact of vitamin D on mammalian gut microbiotaCitation14 but only included evidence from two studies in human infants. Meanwhile, anewer human study identified prenatal vitamin D supplementation as an important predictor of variance in gut microbial profiles of infants.Citation15 In the KOALA birth cohort, Clostridioides difficile counts in 1-month old infants were reduced following maternal prenatal supplementation with multivitamins containing vitamin D.Citation16 Although asymptomatic C. difficile colonization occurs in approximately 30% of young infants, it is less common in breastfed infants and it has been associated with a disrupted gut microbiota composition and later childhood allergic disease. In adults, vitamin D deficiency has also been correlated with C. difficile infection, while community incidence of C. difficile has been associated with RSV and influenza virus circulation.Citation17
Notwithstanding that infant feeding type shapes the infant gut microbiome,Citation18,Citation19 attention is shifting to specific micronutrients. If vitamin D influences the gut microbiome, supplementation during breastfeeding may confer additional benefits.Citation2,Citation20 The primary objective of this study was to determine the association between maternal perinatal and infant vitamin D supplementation, and infant gut microbiota composition at 3 months of age, including C. difficile colonization.
Results
Participant characteristics
At an average age of 3.52 months (SD: 0.97 months), 64.7% of our 1,157 infants received a vitamin D3 supplement (referred to as vitamin D throughout) in the form of vitamin D drops (). A high proportion (74.8%) of exclusively breastfed infants received vitamin D supplements. Supplementation was less frequent in partially (67.8%) and exclusively formula fed infants (25.6%) (). The Manitoba site had the lowest prevalence of infant vitamin D supplementation (43.4% overall, 53.4% in exclusively breastfed infants). Fifteen percent of infants were born to mothers who did not report taking vitamin D supplements or took <400IU/day during pregnancy and lactation, compared to 67% whose mothers reported taking vitamin D supplements (≥400 IU/day) both pre and postnatally.
Table 1. Participant characteristics according to vitamin D supplementation and Clostridioides difficile colonization in all infants.
Overall, 29.7% of infants were colonized with C. difficile, but less among exclusively breastfed infants (22.1%, ). Among those infants who were colonized with C. difficile, mothers were usually younger, had a higher BMI, and were less frequently of Asian ethnicity (). Asmaller proportion of infants colonized with C. difficile were born to mothers who consumed at least 3 cups of fortified milk a day, were more frequently living in homes with furry pets, born in Edmonton and less likely to receive vitamin D drops.
Maternal and infant vitamin D supplement intake is not associated with infant C. difficile colonization
In all infants, direct vitamin D supplementation (OR: 0.76, 95% CI: 0.59–0.99, p = .04), as well as postnatal supplementation (≥ 2 sources of vitamin D, (OR: 0.67, 95% CI: 0.45–0.98, p = .04), were associated with lower odds of C. difficile colonization compared to the absence of supplementation; however, these associations were lost upon adjustment for covariates, notably infant feeding mode. Prenatal maternal vitamin D supplementation was not associated with infant C. difficile colonization in crude or adjusted models.
Within exclusively breastfed infants, the crude odds ratios for C. difficile colonization were not statistically significant with infant vitamin D supplementation (OR: 0.87, 95% CI: 0.57–1.32, p = .585) nor with maternal supplementation (Table S1). These null associations were unchanged following adjustment for birth mode, maternal milk consumption, household pets, study center and infant age at sample collection (, Table S1). No significant interaction terms were discovered between variables. Asensitivity analysis was conducted to ensure that results were not affected by site variations in infant supplementation. No deviations from the main findings were noted for associations between vitamin D supplementation and infant C. difficile colonization after the Manitoba site was excluded (data not shown).
Figure 1. C. difficile colonization according to maternal or infant vitamin D supplementation in the perinatal period.
Independent of infant or maternal prenatal vitamin D supplementation, prenatal maternal milk consumption greater than or equal to 3 cups per day, compared to 1 or less cups per day, was significantly associated with lower odds (aOR: 0.40, 95% CI: 0.19–0.82, p = .01, Table S2) of C. difficile colonization in exclusively breastfed infants. In this final adjusted model, C. difficile colonization was twice more likely in infants born via elective cesarean and in the presence of household pets (Table S2). No associations between vitamin D supplementation and C. difficile colonization were observed (summary ) within partially () or exclusively formula fed infants (Figure S1).
Table 2. Summary of study results. Prevalence of vitamin D supplementation/sources and the association with C. difficile colonization and gut microbiota composition.
Vitamin D supplementation is associated with other compositional changes in infant gut microbiota
Following adjustment for birth mode and feeding mode, microbiota of the genus Megamonas (Veillonellaceae family) were of significantly lower abundance in all infants supplemented with vitamin D (q = 0.01, ). Furthermore, Peptostreptococcus (Peptostreptococcaceae family) were lower in supplemented infants and Eubacterium (Eubacteriaceae family) were depleted in infants whose mothers took a pre and postnatal vitamin D supplement (>400IU/day); however statistical significance for these two genera was lost upon FDR correction ().
Table 3. Gut microbiota composition in all study infants. Multivariate linear regression (MaAsLin) predicting arcsine square root transformed relative abundances of microbiota in all study infants (N = 1,157), exclusively breastfed infants (N = 647), partially breastfed (N = 314) and exclusively formula fed (N = 195) according to postnatal maternal and infant vitamin D supplementation practices.
Exclusively breastfed infants born to mothers who were taking ≥400IU/day both pre and postnatally exhibited a lower relative abundance of Proteobacteria, specifically those of the genus Bilophila (q = 0.01, ). Furthermore, bacteria belonging to the Lachnospiraceae family (q = 0.02) were depleted and microbes belonging to the Pasteurellaceae family (Haemophilus spp., q = 0.02) were enriched compared to infants nursed by mothers taking <400IU/day (). The same modeling procedure was followed for partially and exclusively formula fed infants but none of the associations survived FDR correction (summary ).
Discussion
With the aim to address a gap in emerging discussions on vitamin D and intestinal homeostasis in infants,Citation14 we undertook this gut microbiome study in a general population of 1,157 Canadian mothers and infants. Three-quarters of breastfed infants were supplemented with vitamin D drops and 85% of mothers took vitamin supplements containing ≥400 IU of vitamin D daily during pregnancy and postnatally. At 3–4 months of age, C. difficile colonization of the infant gut was less prevalent with infant vitamin D supplementation but this was explained by the extent of breastfeeding, a strong deterrent of C. difficile.Citation21 Within exclusively breastfed infants, neither infant nor maternal vitamin D supplementation were related to C. difficile colonization status. Whereas C. difficile counts were reportedly lower in colonized, breastfed infants of mothers with prenatal vitamin D intake ≥400 IU/day in the KOALA study, infant C. difficile colonization rates in this cohort did not differ by infant vitamin D supplement intake.Citation16 Our findings agree with those of the KOALA study regarding direct vitamin D supplementation of breastfed infants, for which there were no associations with C. difficile colonization of their gut microbiota.Citation16
However, we found direct vitamin D supplementation of infants to be associated with a lower abundance of Megamonas in gut microbiota. This association was found in all study infants and was independent of feeding mode. While little is known about Megamonas in infancy, this genus was enriched in the gut microbiota of male infants born to mothers with prenatal asthma in a previous publication from the CHILD cohort.Citation22 In addition to childhood asthma, maternal history of asthma is a risk factor for greater severity of viral bronchiolitis in offspring.Citation23 Megamonas has recently been reported to be more abundant in the gut microbiota of adult males with higher testosterone levelsCitation24 and the role of this sex steroid is currently being scrutinized in asthma pathogenesis.Citation25 In view of reported benefits of the vitamin D supplementation of high risk mothers and of infant populations where supplementation is not the norm,Citation7,Citation11 the Megamonas genus of Veillonellaceae may be a possible link between vitamin D and asthma or viral respiratory infection that merits further examination. It would also further support recommendations for the supplementation of formula-fed infants. Vitamin D plays a crucial role in both innate immunity, via toll-like receptor signaling of macrophages in response to pathogens, and adaptive immunity, by inhibiting proliferation of T cells and secretion of inflammatory cytokines.Citation13,Citation26 Further, there is emerging evidence for its role in the lung microbiome and gut-lung axis.Citation27
We also found associations with maternal pre and postnatal vitamin D supplementation (≥400IU/day) in exclusively breastfed infants, namely a lower relative abundance of Bilophila spp. Bilophila have been linked to inflammation and colitis in mice,Citation28,Citation29 and colic in infants.Citation30 Genus Bilophilia produce secondary bile acids, ligands for VDRs, and levels of these microbiota are elevated in the presence of taurine or bile.Citation31–Citation33 Vitamin D receptors are highly expressed in the proximal colon and involved in the production of defensins, cathelicidins, claudins and zonulin occludens, important to gut barrier integrity.Citation12,Citation34,Citation35 Newborns conjugate bile acids with taurine but have the capacity to utilize glycine, especially when fed formula.Citation31–Citation33,Citation36 This may explain why Bilophila species were uniquely altered among exclusively breastfed infants. Maternal supplementation with vitamin D was also associated with depletion of Lachnospiraceae but enhancement of Haemophilus spp, both of which are reported to be altered in mammalian studies of vitamin D.Citation14 The reduction in abundance of Bilophila and other changes to infant gut microbiota following maternal vitamin D supplementation points to pathways involving production of secondary bile acids.
Interestingly, maternal prenatal consumption of 3 or more cups of fortified milk per day reduced the likelihood of C. difficile colonization in exclusively breastfed infants by 60%, even after adjustment for infant vitamin D supplementation, maternal vitamin D supplementation and other covariates (aOR: 0.40, 95% CI: 0.19–0.82, p = .01, Table S2). Transitioning to cow’s milk after exclusive breastfeeding seems to have an inhibitory influence on C. difficile colonization in infants,Citation37 whereas C. difficile infection is more common in children with cow’s milk intolerance.Citation38 Furthermore, greater maternal dietary intake of vitamin D during pregnancy has been reported to reduce risk of cow’s milk allergy in offspring.Citation39 Our findings suggest a putative role of vitamin D fortified-milk consumption during pregnancy but maternal milk consumption may be equally correlated with other maternal dietary patternsCitation40-Citation42 or lifestyle factors (i.e. cleaning product useCitation43) that influence the composition of infant gut microbiota.
Study limitations
An important limitation of this work is that we could not distinguish between those with darker skin pigmentation and other ethnicities, beyond Caucasian and Asian. These populations have been shown to produce less subcutaneous vitamin D, making them at greater risk of low vitamin D.Citation44 We also observed study site differences specifically that the prevalence of Manitoban infant supplementation was lower, in just over 50% of exclusively breastfed infants. According to the sensitivity analysis we conducted, study findings were unchanged if the Manitoba site was excluded.
Finally, we did not have access to maternal or infant serum vitamin D levels. However, for microbiome research, intestinal levels are likely more important than serum levels and reference values for intestinal vitamin D concentrations have yet to be determined. Instead, this study relied on self-report questionnaires for reporting of vitamin D supplementation. Questionnaire response categories did not allow us to explore potential differences within the group of mothers taking more than 400IU/day. Future studies would benefit from a more specific nutrition/supplement question, such as the one administered in the Alberta Pregnancy Outcomes and Nutrition (APrON) study, which was pilot-tested to ensure efficient and detailed collection of vitamin intake and dosing in the Canadian context.Citation45 However, this limitation is not likely to have a large effect on our findings as the APrON study found that the average vitamin D intake during pregnancy from supplements and diet combined was 600 IU/day.Citation46
Ultimately, this study found evidence of an association between maternal vitamin D supplementation with the gut microbiota composition of all study infants, notably a lower abundance of Megamonas, with its potential implications for host defense against viral respiratory infections. In exclusively breastfed infants, we found evidence of an association between direct vitamin D supplementation and lower abundance of Bilophila and members of the Lachnospiraceae, and a higher abundance of Haemophilus at 3-months of age. Yet, vitamin D supplementation did not appear to be associated with C. difficile colonization in any of the feeding groups. It is essential to confirm our findings to fully comprehend the relationship between vitamin D and the gut microbiota of infants, and to understand how current standards of care around vitamin D supplementation support healthy development.
Materials and methods
Study population and design
This observational study included 1,157 families participating in the CHILD Cohort Study.Citation47 Mothers were recruited during their second trimester of pregnancy between January 2009 and December 2012 from the Vancouver, Edmonton or Manitoba sites (inclusion and exclusion criteria outlined at www.childstudy.ca). All study infants provided a fecal sample and data on breastfeeding status and infant vitamin D supplement intake (Figure S2). Mothers provided informed consent upon enrollment and the Human Research Ethics Boards at the University of Manitoba, University of Alberta, and University of British Columbia approved this study.
qPCR for C. difficile detection and 16S sequencing for fecal microbiota analysis
Fecal samples were collected at 3–4 months of age using a standardized protocol during a planned home visit. Methods of sample collection, DNA extraction and amplification, 16S ribosomal RNA sequencing, and microbial taxonomic classification are described elsewhere.Citation18
Briefly, collected samples were aliquoted stored at −80°C until analyzed. DNA extraction was performed using 80–200 mg of frozen sample using the QIAamp DNA Stool Mini kit (Qiagen Inc, Valencia CA). Bacterial 16S rRNA genes were amplified at the hypervariable V4 region and sequenced using the Illumina MiSeq platform (San Diego, CA). Sequences were clustered with USEARCH (version 6.1)Citation48 at >97% similarity against the GREENGENES reference database (version 13.8) for taxonomic classification in QIIME 1.8 and excluded if <60% similarity. Taxon relative abundance was the outcome variable for the microbiota composition analysis. a specific 16S primer was used for targeted amplification and quantification of C. difficile, as described elsewhere.Citation21 Multiplex assays were prepared using the QuantiNova Multiplex PCR Kit (QIAGEN) with appropriate primers and probes. Each qPCR reaction cycle consisted of an initial denaturation for 2 min at 95.0◦C, 40 cycles of denaturation for 5 s at 95◦C and annealing/extension/reading for 20 s at 60◦C and was performed on the MiniOpticonTM Real-Time PCR System (Bio-Rad, Hercules, CA, USA). The outcome variable for C. difficile presence was fecal colonization status, yes/no.
Vitamin D exposure variables
Maternal vitamin D supplementation from various sources (prenatal vitamins, multivitamins or vitamin D supplements, including dose and frequency of intake) was collected in questionnaires during pregnancy (Figure S3) and 3-months postpartum (Figure S4). Mothers were asked about infant supplementation with vitamin D3 drops (referred to as vitamin D throughout) during the first three months (Figure S4). Maternal and infant supplementation variables were created following this algorithm:
i. Maternal prenatal vitamin D intake: a 3-category exposure variable was created from the relevant questionnaire information: 1) One supplement or no supplements containing vitamin D, 2) Two supplements containing vitamin D and 3) Three or more supplements containing vitamin D.
ii. Postnatal vitamin D intake: a 4-category exposure variable was created from the relevant questionnaire information: 1) Low (i.e. one maternal source, no infant direct) or no vitamin D from supplements, 2) Two maternal supplements with vitamin D or infant direct vitamin D, 3) Infant direct and one maternal supplement, and 4) Two or more maternal supplements and infant direct vitamin D.
iii. Maternal perinatal intake based on the dosing information. Based on current Dietary Reference Intakes for vitamin D supplementation of 400 IU/day, and a recommended dietary allowance of 600 IU/day during pregnancy and breastfeeding,Citation44,Citation49 a final 4 category variable was created: 1) No maternal vitamin D or less than 400 IU/day, 2) Prenatal only maternal vitamin D supplementation ≥400 IU/day, 3) Postnatal only maternal vitamin D supplementation ≥400 IU/day and 4) Prenatal and Postnatal supplementation ≥400 IU/day.
Furthermore, mothers reported their milk intake in a food frequency questionnaire administered during pregnancy as milk/fortified substitute beverage consumption (1 cup), milk/fortified substitute use on cereal (1/2 cup) and milk/fortified substitute in tea/coffee (1 Tbsp). To measure dietary sources of vitamin D through fortified milk and/or plant-based alternatives, a 3-category variable was created: 1) 1 or fewer cups/day, 2) 2 cups/day, 3) 3 or more cups/day.
Other covariate data
Data from study questionnaires or medical charts were obtained and used to create the following covariates: season of birth (low UVB season, October – March); high UVB season, April – September),Citation50 maternal pre-pregnancy age and body-mass-index (BMI), infant age at stool collection, hospital length of stay at birth, mode of delivery, infant sex, feeding mode at stool collection (exclusively breastfed [no non-human milk, juices, formula or solids], partially breastfed or exclusively formula fed), antibiotics use, household income, ethnicity, maternal depressive symptoms, pets in the home and study center.
Statistical analysis
All descriptive (Fisher’s exact tests, t-tests, ANOVA) and regression tests were completed using Stata (version 13.0) statistical software and the online Galaxy platform (version 1.0.1). Logistic regression models were used to determine the association between vitamin D supplement use and C. difficile colonization and were built using purposeful selection of covariates.Citation51 ModelsCitation52 were run in all infants, then stratified by feeding mode due to the strong association between breastfeeding and infant vitamin D supplementation. One infant did not have data on feeding mode (stratified analyses, N = 1,156). Microbial taxon abundance was compared using Multivariate Association with Linear Models (MaAsLin), which was adjusted for covariates and subjected to false discovery rate (FDR) correction with q ≤ 0.05.
Supplemental Material
Download MS Word (437.8 KB)Data availability statement
The data and analysis code that support the findings of this study can be made available from the corresponding author and CHILD Cohort Study coordinators upon reasonable request. These data, including study participant data, are securely stored in the https://childdb.ca database.
Supplementary material
Supplemental data for this article can be accessed here.
Additional information
Funding
References
- Canadian Pediatric Society. Vitamin D supplementation: recommendations for Canadian mothers and infants [Internet]. 2017 [accessed 2019 May 1]. https://www.cps.ca/en/documents/position/vitamin-d.
- Centers for Disease Control and Prevention. Vitamin D [Internet]. [accessed 2019 May 1]. https://www.cdc.gov/breastfeeding/breastfeeding-special-circumstances/diet-and-micronutrients/vitamin-d.html
- Uday S, Kongjonaj a, Aguiar M, Tulchinsky T, Högler W. Variations in infant and childhood vitamin D supplementation programmes across Europe and factors influencing adherence. Endocr Connect. 2017;6:667–12.
- Paxton GA, Teale GR, Nowson CA, Mason RS, McGrath JJ, Thompson MJ, Siafarikas a, Rodda CP, Munns CF. Vitamin D and health in pregnancy, infants, children and adolescents in Australia and New Zealand: a position statement. Med J Aust. 2013;198:142–143.
- Ahrens KA, Rossen LM, Simon AE. Adherence to vitamin D recommendations among US infants aged 0 to 11 Months, NHANES, 2009 to 2012. Clin Pediatr (Phila). 2016;55:555–556.
- Fegan S, Bassett E, Peng Y, Steel O’Connor K. Adherence to complementary feeding recommendations for infants and implications for public health. Public Health Nutr. 2016;19:638–649.
- Litonjua AA. Vitamin D and childhood asthma: causation and contribution to disease activity. Curr Opin Allergy Clin Immunol. 2019;19:126–131.
- Hibbs AM, Ross K, Kerns LA, Wagner C, Fuloria M, Groh-Wargo S, Zimmerman T, Minich N, Tatsuoka C. Effect of vitamin D supplementation on recurrent wheezing in black infants who were born preterm: the D-wheeze randomized clinical trial. JAMA. 2018;319:2086.
- Vo P, Koppel C, Espinola JA, Mansbach JM, Celedón JC, Hasegawa K, Bair-Merritt M, Camargo CA. Vitamin D status at the time of hospitalization for bronchiolitis and its association with disease severity. J Pediatr. 2018;203:416–422.e1.
- Ilie PC, Stefanescu S, Smith L. The role of vitamin D in the prevention of coronavirus disease 2019 infection and mortality. Aging Clin Exp Res. 2020;6:1–4.
- Peters RL, Allen KJ, Dharmage SC, Lodge CJ, Koplin JJ, Ponsonby a-L, Wake M, Lowe AJ, Tang MLK, Matheson MC, et al. Differential factors associated with challenge-proven food allergy phenotypes in a population cohort of infants: a latent class analysis. Clin Exp Allergy. 2015;45:953–963.
- Clark a, Mach N. Role of vitamin D in the hygiene hypothesis: the interplay between vitamin D, vitamin D receptors, gut microbiota, and immune response. Front Immunol. 2016;7:627.
- Ooi JH, Chen J, Cantorna MT. Vitamin D regulation of immune function in the gut: why do T cells have vitamin D receptors? Mol Aspects Med. 2012;33:77–82.
- Waterhouse M, Hope B, Krause L, Morrison M, Protani MM, Zakrzewski M, Neale RE. Vitamin D and the gut microbiome: a systematic review of in vivo studies. Eur J Nutr. 2019;58:2895–2910.
- Stewart CJ, Ajami NJ, O’Brien JL, Hutchinson DS, Smith DP, Wong MC, Ross MC, Lloyd RE, Doddapaneni H, Metcalf GA, et al. Temporal development of the gut microbiome in early childhood from the TEDDY study. Nature. 2018;562:583–588.
- Talsness CE, Penders J, Jansen EHJM, Damoiseaux J, Thijs C, Mommers M. Influence of vitamin D on key bacterial taxa in infant microbiota in the KOALA Birth Cohort Study. Plos One. 2017;12:e0188011.
- Gilca R, Fortin É, Frenette C, Longtin Y, Gourdeau M. Seasonal variations in clostridium difficile infections are associated with influenza and respiratory syncytial virus activity independently of antibiotic prescriptions: a time series analysis in Québec, Canada. Antimicrob Agents Chemother. 2012;56:639–646.
- Forbes JD, Azad MB, Vehling L, Tun HM, Konya TB, Guttman DS, Field CJ, Lefebvre D, Sears MR, Becker AB, et al. Association of exposure to formula in the hospital and subsequent infant feeding practices with gut microbiota and risk of overweight in the first year of life. JAMA Pediatr. 2018;172:e181161.
- Ho NT, Li F, Lee-Sarwar KA, Tun HM, Brown BP, Pannaraj PS, Bender JM, Azad MB, Thompson AL, Weiss ST, et al. Meta-analysis of effects of exclusive breastfeeding on infant gut microbiota across populations. Nat Commun. 2018;9:4169.
- Haggerty LL. Maternal supplementation for prevention and treatment of vitamin D deficiency in exclusively breastfed infants. Breastfeed Med. 2011;6:137–144.
- Drall KM, Tun HM, Morales-Lizcano NP, Konya TB, Guttman DS, Field CJ, Mandal R, Wishart DS, Becker AB, Azad MB, et al. Clostridioides difficile colonization is differentially associated with gut microbiome profiles by infant feeding modality at 3–4 months of age. Front Immunol. 2019;10:2866.
- Koleva PT, Tun HM, Konya T, Guttman DS, Becker AB, Mandhane PJ, Turvey SE, Subbarao P, Sears MR, Scott JA, et al. Sex-specific impact of asthma during pregnancy on infant gut microbiota. Eur Respir J. 2017;50:1700280.
- Alvarez AE, Marson FADL, Bertuzzo CS, Arns CW, Ribeiro JD. Epidemiological and genetic characteristics associated with the severity of acute viral bronchiolitis by respiratory syncytial virus. J Pediatr (Rio J). 2013;89:531–543.
- Shin J-H, Park Y-H, Sim M, Kim S-a, Joung H, Shin D-M. Serum level of sex steroid hormone is associated with diversity and profiles of human gut microbiome. Res Microbiol. 2019;170:192–201.
- Talovic M, Sheikh a, McCleary N, Erkkola M, Kaila M, Virtanen SM, Nwaru BI. Periconception endogenous and exogenous maternal sex steroid hormones and risk of asthma and allergy in offspring: protocol for a systematic review and meta-analysis. BMJ Open. 2017;7:e014637.
- Cantorna MT. Vitamin D and Lung Infection. Infect Immun. 2016;84:3094–3096.
- Enaud R, Prevel R, Ciarlo E, Beaufils F, Wieërs G, Guery B, Delhaes L. The gut-lung axis in health and respiratory diseases: a place for inter-organ and inter-kingdom crosstalks. Front Cell Infect Microbiol. 2020;10:9.
- Feng Z, Long W, Hao B, Ding D, Ma X, Zhao L, Pang X. a human stool-derived Bilophila wadsworthia strain caused systemic inflammation in specific-pathogen-free mice. Gut Pathog. 2017;9:59.
- Singh RK, Chang H-W, Yan D, Lee KM, Ucmak D, Wong K, Abrouk M, Farahnik B, Nakamura M, Zhu TH, et al. Influence of diet on the gut microbiome and implications for human health. J Transl Med. 2017;15:73.
- Eutamène H, Garcia-Rodenas CL, Yvon S, d’Aldebert E, Foata F, Berger B, Sauser J, Theodorou V, Bergonzelli G, Mas E. Luminal contents from the gut of colicky infants induce visceral hypersensitivity in mice. Neurogastroenterol Motil. 2017;29:e12994.
- Feng Y, Stams AJM, de Vos Willem M, Sánchez-Andrea I. Enrichment of sulfidogenic bacteria from the human intestinal tract. FEMS Microbiol Lett. 2017;364.
- Ridlon JM, Devendran S, Alves JM, Doden H, Wolf PG, Pereira GV, Ly L, Volland a, Takei H, Nittono H, et al. The ‘in vivo lifestyle’ of bile acid 7α-dehydroxylating bacteria: comparative genomics, metatranscriptomic, and bile acid metabolomics analysis of a defined microbial community in gnotobiotic mice. Gut Microbes. 2019;11:1–24
- Sirajudeen S, Shah I, Al Menhali A. A narrative role of vitamin D and its receptor: with current evidence on the gastric tissues. Int J Mol Sci. 2019;20:3832.
- Sun J. Vitamin D and mucosal immune function. Curr Opin Gastroenterol. 2010;26:591–595.
- Wu S, Liao AP, Xia Y, Chun Li Y, Li J-D, Sartor RB, Sun J. Vitamin D receptor negatively regulates bacterial-stimulated NF-κB activity in intestine. Am J Pathol. 2010;177:686–697.
- Tanaka M, Sanefuji M, Morokuma S, Yoden M, Momoda R, Sonomoto K, Ogawa M, Kato K, Nakayama J. The association between gut microbiota development and maturation of intestinal bile acid metabolism in the first 3 y of healthy Japanese infants. Gut Microbes. 2020;11:205–216.
- Davis MY, Zhang H, Brannan LE, Carman RJ, Boone JH. Rapid change of fecal microbiome and disappearance of Clostridium difficile in a colonized infant after transition from breast milk to cow milk. Microbiome. 2016;4:53.
- Pai S, Aliyu SH, Enoch DA, Karas JA. Five years experience of clostridium difficile infection in children at a UK tertiary hospital: proposed criteria for diagnosis and management. PLoS ONE. 2012;7:e51728.
- Tuokkola J, Luukkainen P, Kaila M, Takkinen H-M, Niinistö S, Veijola R, Virta LJ, Knip M, Simell O, Ilonen J, et al. Maternal dietary folate, folic acid and vitamin D intakes during pregnancy and lactation and the risk of cows’ milk allergy in the offspring. Br J Nutr. 2016;116:710–718.
- Nagy-Szakal D, Ross MC, Dowd SE, Mir SAV, Schaible TD, Petrosino JF, Kellermayer R. Maternal micronutrients can modify colonic mucosal microbiota maturation in murine offspring. Gut Microbes. 2012;3:426–433.
- Bravi F, Wiens F, Decarli a, Dal Pont a, Agostoni C, Ferraroni M. Impact of maternal nutrition on breast-milk composition: a systematic review. Am J Clin Nutr. 2016;104:646–662.
- de Souza R, Zulyniak M, Desai D, Shaikh MR, Campbell NC, Lefebvre DL, Gupta M, Wilson J, Wahi G, Atkinson SA, et al. Harmonization of food-frequency questionnaires and dietary pattern analysis in 4 ethnically diverse birth cohorts. J Nutr. 2016;146:2343–2350.
- Tun MH, Tun HM, Mahoney JJ, Konya TB, Guttman DS, Becker AB, Mandhane PJ, Turvey SE, Subbarao P, Sears MR, et al. Postnatal exposure to household disinfectants, infant gut microbiota and subsequent risk of overweight in children. Can Med Assoc J. 2018;190:E1097–107.
- Ross a, Taylor C, Yaktine a, Del Valle H. Food nutrition board. DRI Dietary reference intakes calcium vitamin D. Washington (DC): National Academies Press; 2011.
- Gómez MF, Field CJ, Olstad DL, Loehr S, Ramage S, McCargar LJ, the APrON Study Team. Use of micronutrient supplements among pregnant women in Alberta: results from the Alberta Pregnancy Outcomes and Nutrition (APrON) cohort: supplement use during pregnancy. Matern Child Nutr. 2015;11:497–510.
- Aghajafari F, Field CJ, Kaplan BJ, Rabi DM, Maggiore JA, O’Beirne M, Hanley DA, Eliasziw M, Dewey D, Weinberg a, et al. The current recommended vitamin D intake guideline for diet and supplements during pregnancy is not adequate to achieve vitamin D sufficiency for most pregnant women. Plos One. 2016;11:e0157262.
- Subbarao P, Anand SS, Becker AB, Befus AD, Brauer M, Brook JR, Denburg JA, HayGlass KT, Kobor MS, Kollmann TR, et al. The Canadian Healthy Infant Longitudinal Development (CHILD) Study: examining developmental origins of allergy and asthma. Thorax. 2015;70:998–1000.
- Kopylova E, Navas-Molina JA, Mercier C, Xu ZZ, Mahé F, He Y, Zhou H-W, Rognes T, Caporaso JG, Knight R. Open-source sequence clustering methods improve the state of the art. mSystems. 2016;1:00003–15,e00003-15.
- Health Canada. Vitamin D and calcium: updated dietary reference intakes [Internet]. [accessed 2019 May 1]. https://www.canada.ca/en/health-canada/services/food-nutrition/healthy-eating/vitamins-minerals/vitamin-calcium-updated-dietary-reference-intakes-nutrition.html.
- Wacker M, Holick M. Vitamin D — effects on skeletal and extraskeletal health and the need for supplementation. Nutrients. 2013;5:111–148.
- Hosmer D, Lemeshow S, Sturdivant R. Applied logistic regression: chapter 4, 3rd ed. New Jersey: John Wiley & Sons Inc; 2013.
- Morgan XC, Tickle TL, Sokol H, Gevers D, Devaney KL, Ward DV, Reyes JA, Shah SA, LeLeiko N, Snapper SB, et al. Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment. Genome Biol. 2012;13:R79.